Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Haemophilia ; 27(1): e78-e87, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33215800

ABSTRACT

INTRODUCTION: Von Willebrand disease (VWD) is the most common inherited bleeding disorder with a prevalence of 0.1%, characterised by quantitative or functional deficiency of von Willebrand factor (VWF). VWD diagnosis is based on symptomology, biochemical and genetic tests, but limited laboratory resources and VWD heterogeneity still generate an important subdiagnosis gap worldwide and in our country. AIM: To identify the type and subtype of VWD in a cohort of patients with a history of excessive bleeding in Western Mexico. METHODS: This prospective cohort study from 2012 to 2019 included patients with mucocutaneous bleeding or abnormal laboratory tests. A standardised questionnaire and confirmatory tests were applied: FVIII:C, VWF activity, VWF antigen, and VWF multimeric analysis. RESULTS: Of the 297 patients recruited, 207 (69.7%) were excluded because their values exceeded 50% in VWF activity and VWF antigen. Of those 90 remaining, 54 (18.2%) had low VWF, and only 36 patients (12.1%) were diagnosed with VWD. Among them, 17 (47.2%) had quantitative deficiencies, of whom 14 were assigned as type 1 and 3 as type 3.The remaining 19 cases were diagnosed as type 2 (52.8%): type 2A and 2B were the most frequent with 6 and 7 cases respectively; 4 cases were possible type 2M and two suggestive of 2N, however, this was not confirmed. CONCLUSION: This study highlights the challenges of VWD diagnosis using a comprehensive panel of diagnostic tests which should extend to supplemental tests of VWF:CB, VWF:FVIIIB, and sequencing the VWD gene to confirm the results from the panel assays.


Subject(s)
von Willebrand Diseases , Hemorrhage , Humans , Mexico/epidemiology , Prospective Studies , von Willebrand Diseases/diagnosis , von Willebrand Diseases/epidemiology , von Willebrand Factor/genetics
2.
J Health Econ ; 58: 253-268, 2018 03.
Article in English | MEDLINE | ID: mdl-29547748

ABSTRACT

This study considers the effects of the kingpin strategy, an approach to fighting organized crime in which law-enforcement efforts focus on capturing the leaders of criminal organizations, on community violence in the context of Mexico's drug war. Newly constructed historical data on drug-trafficking organizations' areas of operation at the municipality level and monthly homicide data allow us to control for a rich set of fixed effects and to leverage variation in the timing of kingpin captures to estimate their effects. This analysis indicates that kingpin captures cause large and sustained increases to the homicide rate in the municipality of capture and smaller but significant effects on other municipalities where the kingpin's organization has a presence, supporting the notion that removing kingpins can have destabilizing effects throughout an organization that are accompanied by escalations in violence. We also find reductions in homicides in municipalities surrounding the municipality where kingpins are captured.


Subject(s)
Crime/prevention & control , Law Enforcement/methods , Violence , Drug Trafficking/prevention & control , Humans , Illicit Drugs , Mexico
3.
Thromb Res ; 136(6): 1291-8, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26493603

ABSTRACT

BACKGROUND: Thrombin generation assay (TGA) is useful as a global functional test for assessing bleeding or thrombotic risk and its modification with therapy. We investigated TGA to assess anticoagulation status compared with the international normalized ratio (INR) system in patients with primary thrombophilia receiving and not undergoing thromboprophylaxis. MATERIALS AND METHODS: We studied 50 patients with at least one thrombotic event and a confirmed diagnosis of inherited thrombophilia. Thrombin generation was measured in platelet-poor plasma by calibrated automated thrombography (CAT). RESULTS: Patients in optimal anticoagulation (INR: 2.0-3.0) showed an endogenous thrombin potential (ETP) of 14-56% of normal and a peak of 18-55% of normal. A significant inverse relationship between INR and thrombin generation parameters (ETP, peak and velocity index) and a linear correlation for lag time was found in patients treated with vitamin-K antagonists (VKA). Receiver-operating characteristics (ROC) analysis showed that the optimal cutoff for ETP was 1600.2 nM · min (111.6% of normal, with a sensitivity of 96.6% and a specificity of 92.9%) and for the peak was 298.3 nM (112.1% of normal, with a sensitivity of 96.4% and a specificity of 100%). According to this analysis, ETP was able to identify patients with increased thrombotic and hemorrhagic risk, correlating with severe clinical complications. CONCLUSION: TGA showed excellent sensitivity and specificity for assessing anticoagulation status in patients with primary thrombophilia receiving VKA, with significant advantages with regard to INR. Clinical data strongly support ETP as a valuable indicator of thrombotic or hemorrhagic risk in patients receiving or not receiving thromboprophylaxis.


Subject(s)
Thrombin/chemistry , Thrombophilia/genetics , Thrombophilia/prevention & control , Adult , Anticoagulants/chemistry , Calibration , Cohort Studies , Female , Healthy Volunteers , Hemorrhage/complications , Heterozygote , Humans , International Normalized Ratio , Male , Middle Aged , Partial Thromboplastin Time , Prothrombin Time , ROC Curve , Risk Factors , Thrombelastography , Thrombosis/complications , Vitamin K/antagonists & inhibitors , Young Adult
4.
Gac Med Mex ; 151(3): 399-402, 2015.
Article in Spanish | MEDLINE | ID: mdl-26089277

ABSTRACT

The diagnosis of von Willebrand disease (vWD) is complex and requires several screening and confirmation tests, such as the analysis of vWF multimers, which is considered the gold standard for vWD subtyping; however, it only discriminates 2A subtype while the 2B, 2M, and 2N subtypes require additional tests and even genetic testing for final confirmation. It is important to consider the patients' hemotype for the vWD diagnosis, particularly in Mexico where hemotype "O" predominates and may entail a 20-25% decreased level of plasma vWF and increased bleeding tendency.


Subject(s)
Algorithms , Genetic Testing/methods , von Willebrand Diseases/diagnosis , ABO Blood-Group System/analysis , Humans , Mexico , von Willebrand Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...